Venture-backed Thrasos Therapeutics hires new SVP and CFO
Thrasos Therapeutics Inc has hired Donald Notman as senior vice president and CFO. Previously, Notman worked at Leerink Partners as managing director and head of private capital markets. Based in Montréal, Thrasos is a biotherapeutics company focused on delivering new solutions for treating kidney disease. Update: In 2012, the company raised $35 million in a round led by SR One and with the participation of GSK Canada Life Sciences Innovation Fund, SW Co, Advanced Technology Ventures, Fonds de solidarité FTQ, Lumira Capital, MP Healthcare Venture Management and Pappas Ventures.
19 June 2014•3 mins read
